Twist Bioscience
TWST
Twist Bioscience (TWST) - Total liabilities
Total liabilities on the balance sheet as of March 2024 : $0.14 B
According to Twist Bioscience 's latest financial reports the company's total liabilities are $0.14 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Twist Bioscience - Total liabilities on balance sheet (from 2017 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-09-30 | $0.15 B | -11.06% |
| 2022-09-30 | $0.17 B | 41.82% |
| 2021-09-30 | $0.12 B | 93.67% |
| 2020-09-30 | $62.62 M | 79.37% |
| 2019-09-30 | $34.91 M | -88.99% |
| 2018-09-30 | $0.31 B | 44.84% |
| 2017-09-30 | $0.21 B | 43.08% |
| 2016-09-30 | $0.15 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $2.69 M | -98.11% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $0.12 B | -14.51% | 🇬🇧 UK |
 Novavax NVAX | $2.51 B | 1,661.85% | 🇺🇸 USA |
 Novocure
NVCR | $0.76 B | 433.98% | Jersey |